Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Activation of opioid receptors in the enteric nervous system. MOR mu... | Download Scientific Diagram
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment | Semantic Scholar
Asymmetric syntheses of (+)- and (–)-collybolide enable reevaluation of kappa-opioid receptor agonism | Organic Chemistry | ChemRxiv | Cambridge Open Engage
The Role of Opioids and Their Receptors in Urological Malignancy: A Review | Journal of Urology
κ-opioid receptor - Wikipedia
Role of Kappa Opioid Receptors in Symptoms of Schizophrenia: What Is the Neurobiology? - Biological Psychiatry
Opioids in cancer: The κ‑opioid receptor (Review)
Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications - JAAD International
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Scientists Just Solved a Major Piece of the Opioid Puzzle | WIRED
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Pathways and Receptors – Opioid Peptides
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Opioid Receptor | kappa, mu Opioid Receptor
Structure of the human κ-opioid receptor in complex with JDTic | Nature
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
